Mesoscopic Assessment of Microstructure in Glioblastomas and Metastases by Merging Advanced Diffusion Imaging with Immunohistopathology

References

1. 1.↵
   2. Young RJ,
   3. Knopp EA

   . Brain MRI: tumor evaluation. J Magn Reson Imaging 2006;24:709–24 doi:10.1002/jmri.20704 pmid:16958058

   CrossRefPubMed
2. 2.↵
   2. Louis DN,
   3. Perry A,
   4. Wesseling P, et al

   . The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 2021;23:1231–51 doi:10.1093/neuonc/noab106 pmid:34185076

   CrossRefPubMed
3. 3.↵
   2. Jacque CM,
   3. Vinner C,
   4. Kujas M, et al

   . Determination of glial fibrillary acidic protein (GFAP) in human brain tumors. J Neurol Sci 1978;35:147–55 doi:10.1016/0022-510x(78)90107-7 pmid:624958

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Eng LF,
   3. Vanderhaeghen JJ,
   4. Bignami A, et al

   . An acidic protein isolated from fibrous astrocytes. Brain Res 1971;28:351–54 doi:10.1016/0006-8993(71)90668-8 pmid:5113526

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Seker-Polat F,
   3. Pinarbasi Degirmenci N,
   4. Solaroglu I, et al

   . Tumor cell infiltration into the brain in glioblastoma: from mechanisms to clinical perspectives. Cancers (Basel) 2022;14:443 doi:10.3390/cancers14020443 pmid:35053605

   CrossRefPubMed
6. 6.↵
   2. Novikov DS,
   3. Jensen JH,
   4. Helpern JA, et al

   . Revealing mesoscopic structural universality with diffusion. Proc Natl Acad Sci U S A 2014;111:5088–93 doi:10.1073/pnas.1316944111 pmid:24706873

   Abstract/FREE Full Text
7. 7.↵
   2. Demerath T,
   3. Donkels C,
   4. Reisert M, et al

   . Gray-white matter blurring of the temporal pole associated with hippocampal sclerosis: a microstructural study involving 3 T MRI and ultrastructural histopathology. Cereb Cortex 2022;32:1882–93 doi:10.1093/cercor/bhab320 pmid:34515307

   CrossRefPubMed
8. 8.↵
   2. Basser PJ,
   3. Pierpaoli C

   . Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. 1996. J Magn Reson 2011;213:560–70 doi:10.1016/j.jmr.2011.09.022 pmid:22152371

   CrossRefPubMed
9. 9.↵
   2. Wang S,
   3. Kim S,
   4. Chawla S, et al

   . Differentiation between glioblastomas and solitary brain metastases using diffusion tensor imaging. Neuroimage 2009;44:653–60 doi:10.1016/j.neuroimage.2008.09.027 pmid:18951985

   CrossRefPubMedWeb of Science
10. 10.↵
    2. Wang S,
    3. Kim SJ,
    4. Poptani H, et al

    . Diagnostic utility of diffusion tensor imaging in differentiating glioblastomas from brain metastases. AJNR Am J Neuroradiol 2014;35:928–34 doi:10.3174/ajnr.A3871 pmid:24503556

    Abstract/FREE Full Text
11. 11.↵
    2. Bette S,
    3. Huber T,
    4. Wiestler B, et al

    . Analysis of fractional anisotropy facilitates differentiation of glioblastoma and brain metastases in a clinical setting. Eur J Radiol 2016;85:2182–87 doi:10.1016/j.ejrad.2016.10.002 pmid:27842664

    CrossRefPubMed
12. 12.↵
    2. Mao J,
    3. Zeng W,
    4. Zhang Q, et al

    . Differentiation between high-grade gliomas and solitary brain metastases: a comparison of five diffusion-weighted MRI models. BMC Med Imaging 2020;20:124 doi:10.1186/s12880-020-00524-w pmid:33228564

    CrossRefPubMed
13. 13.↵
    2. Nguyen DH,
    3. Le TD,
    4. Nguyen HV, et al

    . Discriminating glioblastoma from solitary brain metastases on 3 Tesla magnetic resonance imaging: the roles of fractional anisotropy and mean diffusivity. Eur Rev Med Pharmacol Sci 2022;26:8823–31 doi:10.26355/eurrev_202212_30554 pmid:36524501

    CrossRefPubMed
14. 14.↵
    2. Tsougos I,
    3. Svolos P,
    4. Kousi E, et al

    . Differentiation of glioblastoma multiforme from metastatic brain tumor using proton magnetic resonance spectroscopy, diffusion and perfusion metrics at 3 T. Cancer Imaging 2012;12:423–36 doi:10.1102/1470-7330.2012.0038 pmid:23108208

    CrossRefPubMed
15. 15.↵
    2. Kadota Y,
    3. Hirai T,
    4. Azuma M, et al

    . Differentiation between glioblastoma and solitary brain metastasis using neurite orientation dispersion and density imaging. J Neuroradiol 2020;47:197–202 doi:10.1016/j.neurad.2018.10.005 pmid:30439396

    CrossRefPubMed
16. 16.↵
    2. Wang W,
    3. Steward CE,
    4. Desmond PM

    . Diffusion tensor imaging in glioblastoma multiforme and brain metastases: the role of p, q, L, and fractional anisotropy. AJNR Am J Neuroradiol 2009;30:203–08 doi:10.3174/ajnr.A1303 pmid:18842762

    Abstract/FREE Full Text
17. 17.↵
    2. Preziosa P,
    3. Kiljan S,
    4. Steenwijk MD, et al

    . Axonal degeneration as substrate of fractional anisotropy abnormalities in multiple sclerosis cortex. Brain 2019;142:1921–37 doi:10.1093/brain/awz143 pmid:31168614

    CrossRefPubMed
18. 18.↵
    2. Galbusera R,
    3. Bahn E,
    4. Weigel M, et al

    . Postmortem quantitative MRI disentangles histological lesion types in multiple sclerosis. Brain Pathol 2022 Dec 8. [Epub ahead of print] doi:10.1111/bpa.13136 pmid:36480267

    CrossRefPubMed
19. 19.↵
    2. Lee JK,
    3. Liu D,
    4. Jiang D, et al

    . Fractional anisotropy from diffusion tensor imaging correlates with acute astrocyte and myelin swelling in neonatal swine models of excitotoxic and hypoxic-ischemic brain injury. J Comp Neurol 2021;529:2750–70 doi:10.1002/cne.25121 pmid:33543493

    CrossRefPubMed
20. 20.↵
    2. Szczepankiewicz F,
    3. Lasič S,
    4. van Westen D, et al

    . Quantification of microscopic diffusion anisotropy disentangles effects of orientation dispersion from microstructure: applications in healthy volunteers and in brain tumors. Neuroimage 2015;104:241–52 doi:10.1016/j.neuroimage.2014.09.057 pmid:25284306

    CrossRefPubMed
21. 21.↵
    2. Rau A,
    3. Reisert M,
    4. Kellner E, et al

    . Increased interstitial fluid in periventricular and deep white matter hyperintensities in patients with suspected idiopathic normal pressure hydrocephalus. Sci Rep 2021;11:19552 doi:10.1038/s41598-021-98054-0 pmid:34599204

    CrossRefPubMed
22. 22.↵
    2. Würtemberger U,
    3. Diebold M,
    4. Erny D, et al

    . Diffusion microstructure imaging to analyze perilesional T2 signal changes in brain metastases and glioblastomas. Cancers (Basel) 2022;14:1155 doi:10.3390/cancers14051155 pmid:35267463

    CrossRefPubMed
23. 23.↵
    2. Würtemberger U,
    3. Rau A,
    4. Reisert M, et al

    . Differentiation of perilesional edema in glioblastomas and brain metastases: comparison of diffusion tensor imaging, neurite orientation dispersion and density imaging and diffusion microstructure imaging. Cancers (Basel) 2022;15:129 doi:10.3390/cancers15010129 pmid:36612127

    CrossRefPubMed
24. 24.↵
    2. Veraart J,
    3. Novikov DS,
    4. Christiaens D, et al

    . Denoising of diffusion MRI using random matrix theory. Neuroimage 2016;142:394–406 doi:10.1016/j.neuroimage.2016.08.016 pmid:27523449

    CrossRefPubMed
25. 25.↵
    2. Kellner E,
    3. Dhital B,
    4. Kiselev VG, et al

    . Gibbs-ringing artifact removal based on local subvoxel-shifts. Magn Reson Med 2016;76:1574–81 doi:10.1002/mrm.26054 pmid:26745823

    CrossRefPubMed
26. 26.↵
    2. Reisert M,
    3. Kellner E,
    4. Dhital B, et al

    . Disentangling micro from mesostructure by diffusion MRI: a Bayesian approach. Neuroimage 2017;147:964–75 doi:10.1016/j.neuroimage.2016.09.058 pmid:27746388

    CrossRefPubMed
27. 27.↵
    2. Daducci A,
    3. Canales-Rodríguez EJ,
    4. Zhang H, et al

    . Accelerated Microstructure Imaging via Convex Optimization (AMICO) from diffusion MRI data. Neuroimage 2015;105:32–44 doi:10.1016/j.neuroimage.2014.10.026 pmid:25462697

    CrossRefPubMed
28. 28.↵
    2. Eidel O,
    3. Burth S,
    4. Neumann JO, et al

    . Tumor infiltration in enhancing and non-enhancing parts of glioblastoma: a correlation with histopathology. PLoS One 2017;12:e0169292 doi:10.1371/journal.pone.0169292 pmid:28103256

    CrossRefPubMed
29. 29.↵
    2. Berghoff AS,
    3. Rajky O,
    4. Winkler F, et al

    . Invasion patterns in brain metastases of solid cancers. Neuro Oncol 2013;15:1664–72 doi:10.1093/neuonc/not112 pmid:24084410

    CrossRefPubMed
30. 30.↵
    2. Sahm F,
    3. Capper D,
    4. Jeibmann A, et al

    . Addressing diffuse glioma as a systemic brain disease with single-cell analysis. Arch Neurol 2012;69:523–26 doi:10.1001/archneurol.2011.2910 pmid:22158715

    CrossRefPubMedWeb of Science
31. 31.↵
    2. Venkataramani V,
    3. Schneider M,
    4. Giordano FA, et al

    . Disconnecting multicellular networks in brain tumours. Nat Rev Cancer 2022;22:481–91 doi:10.1038/s41568-022-00475-0 pmid:35488036

    CrossRefPubMed
32. 32.↵
    2. Barajas RF,
    3. Phillips JJ,
    4. Parvataneni R, et al

    . Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR imaging. Neuro Oncol 2012;14:942–54 doi:10.1093/neuonc/nos128 pmid:22711606

    CrossRefPubMed
33. 33.↵
    2. Zhang H,
    3. Hubbard PL,
    4. Parker GJM, et al

    . Axon diameter mapping in the presence of orientation dispersion with diffusion MRI. Neuroimage 2011;56:1301–15 doi:10.1016/j.neuroimage.2011.01.084 pmid:21316474

    CrossRefPubMed
34. 34.↵
    2. Zhang H,
    3. Schneider T,
    4. Wheeler-Kingshott CA, et al

    . NODDI: practical in vivo neurite orientation dispersion and density imaging of the human brain. Neuroimage 2012;61:1000–16 doi:10.1016/j.neuroimage.2012.03.072 pmid:22484410

    CrossRefPubMed
35. 35.↵
    2. Panagiotaki E,
    3. Walker-Samuel S,
    4. Siow B, et al

    . Noninvasive quantification of solid tumor microstructure using VERDICT MRI. Cancer Res 2014;74:1902–12 doi:10.1158/0008-5472.CAN-13-2511 pmid:24491802

    Abstract/FREE Full Text
36. 36.↵
    2. Zaccagna F,
    3. Riemer F,
    4. Priest AN, et al

    . Non-invasive assessment of glioma microstructure using VERDICT MRI: correlation with histology. Eur Radiol 2019;29:5559–66 doi:10.1007/s00330-019-6011-8 pmid:30888488

    CrossRefPubMed